The United States Defense Advanced Research Projects Agency (DARPA) is investigating Moderna, a company developing a much hyped COVID-19 vaccine candidate, for allegedly failing to disclose federal funding on its US patent applications. A Moderna spokesperson on Monday told Health Policy Watch that “the Company believes it has complied with applicable patent reporting requirements regarding patent filings.” […] Continue reading ->
The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a  € 400 million commitment – inching the visionary global fund much closer to reality.   If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading ->
Russia’s speedy approval of a COVID-19 vaccine on Tuesday has drawn widespread criticism from Health Ministers, researchers, and even a Russian pharma industry group.  However, it has also spurred interest and offers to collaborate on testing the new vaccine in other countries, including from quarters as farflung as Israel and the Philippines. The Russian COVID-19 […] Continue reading ->
More than US $100 billion will be required just to scale-up manufacturing and ensure worldwide distribution of a coronavirus vaccine, said WHO Director-General Dr Tedros Adhanom Ghebreyesus in prepared remarks at a WHO press conference on Monday. He said that the World Health Organization’s ACT Accelerator consortium has received only 10% of the funding that […] Continue reading ->
To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading ->